H1 Blog

JULY 30, 2024

Increasing diversity in clinical trials not only makes the findings more relevant to various patient groups, but also enhances knowledge about the disease or medical product being studied. The recent draft by the FDA introduces additional guidelines for Diversity Action Plans aimed at improving diversity in clinical research.

FDA 59

FDA Clinical Trials Compliance Pharma Companies 59

Vial

JUNE 24, 2024

The fields of artificial intelligence (AI) and machine learning (ML) are increasingly influencing clinical research and development (R&D). Contract research organizations (CROs) and pharmaceutical companies can leverage these cutting-edge technologies to streamline clinical trials and introduce automation in drug discovery.

Clinical Trials 52

Clinical Trials Trials Clinical Research Treatment 52

H1 Blog

NOVEMBER 29, 2023

Data sharing is crucial for promoting scientific discoveries and informed decision-making in clinical practice. Without access to all the relevant data, researchers are unable to fully understand the complexities of diseases and develop effective treatments. To learn more, request a demo.

Clinical Trials 59

Clinical Trials Trials Drug Development Treatment 59